OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural compounds fromClerodendrumspp. as possible therapeutic candidates against SARS-CoV-2: Anin silicoinvestigation
Pallab Kar, Neeta Raj Sharma, Bhupender Singh, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 13, pp. 4774-4785
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
Nisha Muralidharan, Ramasamy Sakthivel, D. Velmurugan, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 7, pp. 2673-2678
Closed Access | Times Cited: 429

Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1306-1344
Open Access | Times Cited: 69

Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study
Shafi Mahmud, Gobindo Kumar Paul, Mirola Afroze, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2210-2210
Open Access | Times Cited: 92

Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus
Akinwunmi Oluwaseun Adeoye, Babatunde Joseph Oso, Ige Olaoye, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 10, pp. 3469-3479
Open Access | Times Cited: 80

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58

Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19
Arpana Parihar, Zannatul Ferdous Sonia, Farjana Akter, et al.
Computers in Biology and Medicine (2022) Vol. 145, pp. 105468-105468
Open Access | Times Cited: 53

Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26

Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, et al.
International Journal of Biological Macromolecules (2023) Vol. 237, pp. 124169-124169
Open Access | Times Cited: 24

Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation
Pallab Kar, Vijay Kumar, Balachandar Vellingiri, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 10, pp. 4532-4542
Open Access | Times Cited: 51

In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19
Somdutt Mujwar, Ranjit K. Harwansh
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1517-1528
Open Access | Times Cited: 31

Theaflavin 3-gallate inhibits the main protease (Mpro) of SARS-CoV-2 and reduces its count in vitro
Mahima Chauhan, Vijay Kumar Bhardwaj, Asheesh Kumar, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28

In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
İsmail Çeli̇k, Meryem Erol, Zekeriya Düzgün
Molecular Diversity (2021) Vol. 26, Iss. 1, pp. 279-292
Open Access | Times Cited: 39

Friedelin and 3β-Friedelinol: Pharmacological Activities
Mai Hussin Radi, Riham A. El‐Shiekh, Ali M. El-Halawany, et al.
Revista Brasileira de Farmacognosia (2023) Vol. 33, Iss. 5, pp. 886-900
Open Access | Times Cited: 14

Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic
Dimitriοs Vlachakis, Eleni Papakonstantinou, Τhanasis Mitsis, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111805-111805
Open Access | Times Cited: 37

Potential Nutraceuticals for COVID-19
Sayali Savant, Shraddha Srinivasan, Anil Kumar Kruthiventi
Nutrition and Dietary Supplements (2021) Vol. Volume 13, pp. 25-51
Open Access | Times Cited: 27

In-silico strategies of some selected phytoconstituents from Melissa officinalis as SARS CoV-2 main protease and spike protein (COVID-19) inhibitors
DSNBK Prasanth, Manikanta Murahari, Vivek Chandramohan, et al.
Molecular Simulation (2021) Vol. 47, Iss. 6, pp. 457-470
Open Access | Times Cited: 26

Clerodendrum trichotomum Thunberg—An Ornamental Shrub with Medical Properties
Jan Gomulski, Izabela Grzegorczyk-Karolak
Molecules (2024) Vol. 29, Iss. 14, pp. 3272-3272
Open Access | Times Cited: 3

In silico screening predicts common cold drug Dextromethorphan along with Prednisolone and Dexamethasone can be effective against novel Coronavirus disease (COVID-19)
Indrani Sarkar, Arnab Sen
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 8, pp. 3706-3710
Open Access | Times Cited: 25

In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (Mpro) structure of SARS-CoV-2
S. Birendra Kumar, Parasuraman Pavadai, T. P. Krishna Murthy, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 7796-7814
Closed Access | Times Cited: 22

Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review
Maria Eleonora Bizzoca, Stefania Leuci, Michele Davide Mignogna, et al.
Food Science and Human Wellness (2022) Vol. 11, Iss. 5, pp. 1134-1142
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top